← Leaderboards
Stephen Marc Schwartz
Fred Hutchinson Cancer Research Center
$21,149,027
Attributed
$26,024,530
Total exposure
13
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.1M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$27,627,401 · 14
By mechanism
R01$14,931,754 · 5
U01$5,513,156 · 1
T32$3,291,445 · 1
P50$1,602,871 · 1
P60$858,732 · 1
U54$702,192 · 1
Top collaborators
- Ruth D Etzioni5 shared
- Peter A Kanetsky4 shared
- Katherine L Nathanson4 shared
- Michael Chiao-An Wu2 shared
Most similar at Fred Hutchinson Cancer Research Center
Same institution · by research overlap
- Margaret M Madeleine$13,649,862
- Janet R Daling$9,948,750
- Johanna W Lampe$31,062,945
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsResearch PersonnelHuman SubjectResourcesFundingEpidemiologyClinical ResearchSamplingRisk FactorsGenotypeTestosteroneNeoplasm /Cancer EpidemiologyBaseCollaborationsGene Environment InteractionProgramsHormone Regulation /Control MechanismBiometryGeneticDesignCancer RiskMaleCommunitiesGenetic Polymorphism
Grant awards (55)
Developing Data-Driven Cancer Researchers$381,472
T32 · FY2025 · CA · contact PI
Developing Data-Driven Cancer Researchers$310,641
T32 · FY2024 · CA · contact PI
NCI PATTERNS OF CARE STUDY - DIAGNOSIS YEAR 2021 (PROSTATE CANCER AND OVARIAN CANCER)$104,718
N02 · FY2024 · CA · contact PI
Developing Data-Driven Cancer Researchers$319,154
T32 · FY2022 · CA · contact PI
Research Methods Core$232,280
P60 · FY2022 · AA · contact PI
Developing Data-Driven Cancer Researchers$412,931
T32 · FY2021 · CA · contact PI
Research Methods Core$153,217
P60 · FY2021 · AA · contact PI
Developing Data-Driven Cancer Researchers$359,570
T32 · FY2020 · CA · contact PI
Research Methods Core$134,122
P60 · FY2020 · AA · contact PI
Methodology Core$114,259
U54 · FY2020 · MD · contact PI
Developing Data-Driven Cancer Researchers$345,930
T32 · FY2019 · CA · contact PI
Research Methods Core$149,337
P60 · FY2019 · AA · contact PI
Methodology Core$134,618
U54 · FY2019 · MD · contact PI
Developing Data-Driven Cancer Researchers$270,433
T32 · FY2018 · CA · contact PI
Research Methods Core$189,776
P60 · FY2018 · AA · contact PI
Methodology Core$129,378
U54 · FY2018 · MD · contact PI
Methodology Core$147,351
U54 · FY2017 · MD · contact PI
Cancer Epidemiology and Biostatistics Training$2,716
T32 · FY2017 · CA · contact PI
Cancer Epidemiology and Biostatistics Training$463,648
T32 · FY2016 · CA · contact PI
Methodology Core$176,586
U54 · FY2016 · MD · contact PI
Post GWA Studies in Testicular Germ Cell Tumors$1,374,735
U01 · FY2015 · CA
Cancer Epidemiology and Biostatistics Training$424,950
T32 · FY2015 · CA · contact PI
Center for Native Population Health Disparities$1,602,871
P50 · FY2014 · CA · contact PI
Post GWA Studies in Testicular Germ Cell Tumors$1,497,780
U01 · FY2014 · CA
Post GWA Studies in Testicular Germ Cell Tumors$1,451,724
U01 · FY2013 · CA
Post GWA Studies in Testicular Germ Cell Tumors$1,188,917
U01 · FY2012 · CA
Molecular Epidemiology of Testicular Carcinoma$948,055
R01 · FY2009 · CA · contact PI
Immunogenetics of Cervical and Vulvar Cancer$619,763
R01 · FY2009 · CA · contact PI
Molecular Epidemiology of Testicular Carcinoma$949,937
R01 · FY2008 · CA · contact PI
Immunogenetics of Cervical and Vulvar Cancer$607,277
R01 · FY2008 · CA · contact PI
Molecular Epidemiology of Testicular Carcinoma$962,266
R01 · FY2007 · CA · contact PI
Immunogenetics of Cervical and Vulvar Cancer$637,816
R01 · FY2007 · CA · contact PI
CORE--EPIDEMIOLOGY RESOURCE$104,061
P30 · FY2007 · CA · contact PI
Molecular Epidemiology of Testicular Carcinoma$965,051
R01 · FY2006 · CA · contact PI
Immunogenetics of Cervical and Vulvar Cancer$657,834
R01 · FY2006 · CA · contact PI
Molecular Epidemiology of Testicular Carcinoma$962,652
R01 · FY2005 · CA
Immunogenetics of Cervical and Vulvar Cancer$669,096
R01 · FY2005 · CA
Immunogenetics of Cervical Cancer A Family-Based Design$86,500
R03 · FY2005 · CA
MOLECULAR EPIDEMIOLOGY OF TESTICULAR CARCINOMA$944,177
R01 · FY2004 · CA
Persistent Organochlorines and Testicular Cancer Risk$383,349
R01 · FY2004 · CA
Immunogenetics of Cervical Cancer: A Family-Based Design$86,500
R03 · FY2004 · CA
MOLECULAR EPIDEMIOLOGY OF TESTICULAR CARCINOMA$930,065
R01 · FY2003 · CA
Persistent Organochlorines and Testicular Cancer Risk$379,331
R01 · FY2003 · CA
CORE--EPIDEMIOLOGY RESOURCE$64,754
P30 · FY2003 · CA
MOLECULAR EPIDEMIOLOGY OF TESTICULAR CARCINOMA$830,860
R01 · FY2002 · CA
Persistent Organochlorines and Testicular Cancer Risk$297,188
R01 · FY2002 · CA
Molecular Epidemiology of Testicular Carcinoma$43,250
R01 · FY2002 · CA
COMMON VARIANTS IN CANDIDATE GENES AND PREMATURE MI RISK$684,701
R01 · FY2001 · HL
MOLECULAR EPIDEMIOLOGY OF TESTICULAR CARCINOMA$489,963
R01 · FY2001 · CA
Persistent Organochlorines and Testicular Cancer Risk$297,350
R01 · FY2001 · CA
ORAL CANCER--DNA POLYMORPHISMS IN CARCINOGEN METABOLISM$92,657
R01 · FY2001 · DE
COMMON VARIANTS IN CANDIDATE GENES AND PREMATURE MI RISK$853,124
R01 · FY2000 · HL
MOLECULAR EPIDEMIOLOGY OF TESTICULAR CARCINOMA$403,478
R01 · FY2000 · CA
ORAL CANCER--DNA POLYMORPHISMS IN CARCINOGEN METABOLISM$322,514
R01 · FY2000 · DE
HUMAN PAPILLOMAVIRUS AND PROGNOSIS OF FEMALE ANOGENITAL CANCER$280,718
P01 · FY2000 · CA